Skip to main content

Table 5 Disease activity at baseline and 6 months as measured on the patient subjective measure of disease activity and disease activity indices

From: Cognitive-behavioural therapy has no effect on disease activity but improves quality of life in subgroups of patients with inflammatory bowel disease: a pilot randomised controlled trial

  +CBT SC
  n (%)
  Baseline 6 months 12 months Baseline 6 months 12 months
n = 90 n = 51 n = 42 n = 84 n = 65 n = 64
IBD control Very well 27 (30) 18 (35) 14 (33) 18 (21.4) 17 (26.1) 27 (42)
  Reasonably 54 (60) 26 (50) 18 (43) 56 (66.7) 35 (53.8) 30 (47)
  Not well 7 (8) 3 (6) 5 (12) 6 (7.1) 7 (10.8) 3 (5)
CDAI Active >150 15 (17) 8 (16) 5 (12) 11 (13.1) 8 (12.3) 8 (12)
SCCAI# Active >3 8 (9) 8 (16) 6 (14) 10 (11.9) 14 (21.5) 9 (14)
   Mean (SD)  
CDAI   110.8 (72.5) 91.3 (90.3) 84.1 (95.3) 87.4 (104.8) 83.2 (92.2) 88.4 (105.9)
SCCAI   3.4 (1.4) 3.5 (1.8) 2.9 (1.6) 3.2 (1.3) 3.7 (1.6) 3.5 (2.5)
  1. #Contrary to the commonly used cut off point of >2, in this study SCCAI was considered normal between 0 and 3 as only few participants (all considered by doctors to be in remission) had a score below 3 with subscore of 0 for rectal bleeding.